In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Andressa da Silva CazoteLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-3775-6923 Glenda Domingos MascarenhasLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Hugo PerazzoInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Kim Mattos GeraldoInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Maria Pia Diniz RibeiroInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0001-7274-6838 Juliana Arruda de MatosInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Pedro Emmanuel Alvarenga Americano do BrasilInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-6700-2268 Sandra Wagner CardosoInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Valdiléa Gonçalves VelosoInstituto Nacional de Infectologia Evandro Chagas (INI), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Cynthia Machado CascabulhoFlow Cytometry Platform-Multiparametric Analysis Unit, Oswaldo Cruz Institute, Rio de Janeiro 21040-360, Brazil.
José Henrique PilottoLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-0521-8597 Diogo Gama CaetanoLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-8889-0655 Milena Neira Guimarães GoulartLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
Nathalia Beatriz Ramos de SáLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-1084-6435 Dalziza Victalina de AlmeidaLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-0917-0009 Fernanda Heloise CôrtesLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-1416-0657 Mariza Gonçalves MorgadoLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-9304-6184 Carmem Beatriz Wagner Giacoia-GrippLaboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-0424-5219 Funding
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro-FAPERJ SEI-260003/002689/2020Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro-FAPERJ SEI-260003/013002/2021INOVA FIOCRUZ/Fundação Oswaldo Cruz 48401996705881
6 · The paper itselfAbstract
This study aimed to identify the distinct intrinsic response potential of γδ T cells from COVID-19 patients with different illness severities, to better understand the implication of these cells in COVID-19 disease. Forty-four COVID patients were enrolled at hospitalization and classified as: moderate without oxygen support (MWO
Indexed as
COVID-19Receptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAdultAgedBrazilCross-Sectional StudiesFemaleHumansInterleukin-17MaleMiddle AgedSARS-CoV-2Severity of Illness IndexInterleukin-17Receptors, Antigen, T-Cell, gamma-deltaCOVID-19disease severityγδ T cells
Identifiers
PMID42274612
PMCPMC13256624
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390